Order Article Reprints

Woo TE, Stukalin I, Ding PQ, Goutam S, Sander M, Ewanchuk B, Cheung WY, Heng DYC, Cheng T. Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma. Current Oncology. 2023; 30(10):8936-8947. https://doi.org/10.3390/curroncol30100646

Woo, Taylor E., Igor Stukalin, Philip Q. Ding, Siddhartha Goutam, Michael Sander, Benjamin Ewanchuk, Winson Y. Cheung, Daniel Y. C. Heng, and Tina Cheng. 2023. "Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma" Current Oncology 30, no. 10: 8936-8947. https://doi.org/10.3390/curroncol30100646

Woo, T. E., Stukalin, I., Ding, P. Q., Goutam, S., Sander, M., Ewanchuk, B., Cheung, W. Y., Heng, D. Y. C., & Cheng, T. (2023). Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma. Current Oncology, 30(10), 8936-8947. https://doi.org/10.3390/curroncol30100646